On January 10, 2017, 2016 Annual Report meeting of the Hepatoma Research was held. The Managing Editor of Hepatoma Research, Lisa Huang, presented an overall review of the development of the Journal over the past year to all members of the editorial office. A summary of the key events of what has been a very busy year follows.
During 2016, under the direction of our Editor-in-Chief Prof. Joseph F. Buell, and through the joint effort of all the Editorial Board Members and members of the editorial office, with the support of reviewers, readers, and authors, Hepatoma Research has made gratifying progress in many aspects of its development.
By December 31, 2016, Hepatoma Research had published 52 articles on the OAE Publishing Inc. website, including 15 original articles, 11 reviews, 8 case reports, 3 commentaries, 2 letters to the Editor, and 1 brief communication. Among the 52 articles, two special issues are included: “Natural Products and Hepatocellular Carcinoma”, organized by our Editorial Board member, Prof. Mosaad A. Abdel-Wahhab, and “Advances in Minimally Invasive Cirrhotic Surgery”, organized by another Editorial Board member, Prof. Giulio Belli.
Figure 1: TYPOLOGY OF 2016 PUBLISHED ARTICLES
Figure 2: 2016 ARTICLES BY COUNTRY OF AUTHOR
Compared with the articles published in 2015, the quality of our articles in 2016 has greatly improved thanks to a more scientific and rigorous peer-review process. In the course of the past year, Hepatoma Research has been closely followed by global experts in the liver cancer research field and has acquired a broad readership, as well as becoming a favorite site for authors. Up to December 31, 2016, the 52 articles published in 2016 had been viewed 55,353 times, and the top five most-read articles were:
|Hepatitis B virus molecular biology and pathogenesis|
Michael J. Bouchard
|Physiological potential of cytokines and liver damages|
Fathia A. Mannaa
|Curcumin: an adjuvant therapeutic remedy for liver cancer|
|Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies|
|Beneficial and detrimental effects of natural dietary products on the risk of hepatocellular carcinoma, and their roles in its management|
Over the last year, the journal cooperated with four international academic conferences in the liver cancer field, including: the 10th International Liver Cancer Association Annual Conference (ILCA), held at the Fairmont Hotel Vancouver, September 9-11, 2016 in Vancouver, Canada.
This year, journal staff will attend the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), which will be held on February 15-19, 2017 in Shanghai, China.
Hepatoma Research also actively participated in many international conferences such as the AACR, MRS, CSCO, etc., to promote the influence of the journal, which earned the praise and encouragement of experts present at the conferences. In addition, Hepatoma Research has been indexed by CAS, Google Scholar, Wanfang Data, DRJI, Open J-Gate, SHERPA/RoMEO, CNKI, ResearchBib, and the Bielefeld Academic Search Engine (BASE). Through such efforts, the global influence of the journal has been constantly expanded and it is becoming known to an ever-increasing number of experts and readers. As of December 31, 2016, the readers of the journal are distributed around 133 countries. The top two countries for readership are China and United States, and the detailed distribution can be seen in the following figure:
Figure 3: 2016 READERSHIP BY COUNTRY
There are now 138 members on the Editorial Board of Hepatoma Research. At the end of 2016, another 16 Chinese experts joined the Editorial Board. The Vice-Chairman of the Chinese Society of Clinical Oncology, Prof. Shu-Kui Qin, now serves as the Honorary Editor-in-Chief of the journal. The Dean of Zhongshan Hospital, Fudan University, China, Jia Fan, who has made an outstanding contribution to clinical research into liver cancer, and Feng Shen, Vice-President of the Shanghai Eastern Hepatobiliary Surgery Hospital, also joined the Editorial Board to give their opinions on the development of Hepatoma Research.
In the challenging year of 2016, we never slackened in our efforts. Whether dealing with the manuscripts submitted or participating in a conference, we set ourselves the highest standards in the quality of papers, the rigorous peer-review process, and adhering to international ethical standards and international publishing specifications. We shall continue to do our utmost to make Hepatoma Research a better publication by drawing on our growing knowledge and abilities. In the coming year of 2017, we will continue in our mission to publish high-quality articles as the basic point of departure and continue to strive to create a journal of the very highest quality.
Respectfully submitted by Lisa Huang, Managing Editor.